Mortality of patients with ST-segment-elevation myocardial infarction without standard modifiable risk factors among patients without known coronary artery disease: Age-stratified and sex-related analysis from nationwide readmissions database 2010-2014

[1]  E. Hagström,et al.  Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data , 2021, The Lancet.

[2]  G. Figtree,et al.  Progression of coronary atherosclerosis in patients without standard modifiable risk factors , 2020, American journal of preventive cardiology.

[3]  Z. Fayad,et al.  Disentangling the Links Between Psychosocial Stress and Cardiovascular Disease , 2020, Circulation. Cardiovascular imaging.

[4]  Robert M. Minutello,et al.  Associations Between Hospital Length of Stay, 30‐Day Readmission, and Costs in ST‐Segment–Elevation Myocardial Infarction After Primary Percutaneous Coronary Intervention: A Nationwide Readmissions Database Analysis , 2020, Journal of the American Heart Association.

[5]  Sadeer G. Al-Kindi,et al.  Environmental determinants of cardiovascular disease: lessons learned from air pollution , 2020, Nature Reviews Cardiology.

[6]  M. Budoff,et al.  Association of psychosocial traits with coronary artery calcium development and progression: The Multi-Ethnic Study of Atherosclerosis. , 2020, Journal of cardiovascular computed tomography.

[7]  P. Elliott,et al.  Predictive Accuracy of a Polygenic Risk Score-Enhanced Prediction Model vs a Clinical Risk Score for Coronary Artery Disease. , 2020, JAMA.

[8]  G. Figtree,et al.  ST‐Segment–Elevation Myocardial Infarction (STEMI) Patients Without Standard Modifiable Cardiovascular Risk Factors—How Common Are They, and What Are Their Outcomes? , 2019, Journal of the American Heart Association.

[9]  R. Swaminathan,et al.  Thirty‐Day Readmission Rates, Timing, Causes, and Costs after ST‐Segment–Elevation Myocardial Infarction in the United States: A National Readmission Database Analysis 2010–2014 , 2018, Journal of the American Heart Association.

[10]  I. Thylén,et al.  Gender differences in symptom presentation of ST-elevation myocardial infarction - An observational multicenter survey study. , 2018, International journal of cardiology.

[11]  V. Figueredo,et al.  Etiologies, predictors, and economic impact of readmission within 1 month among patients with takotsubo cardiomyopathy , 2018, Clinical cardiology.

[12]  Mary E. Haas,et al.  Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations , 2018, Nature Genetics.

[13]  T. Henry,et al.  Sex‐based differences in quality of care and outcomes in a health system using a standardized STEMI protocol , 2017, American heart journal.

[14]  Leora I. Horwitz,et al.  Association of Changing Hospital Readmission Rates With Mortality Rates After Hospital Discharge , 2017, JAMA.

[15]  M. Ward,et al.  Increasing proportion of ST elevation myocardial infarction patients with coronary atherosclerosis poorly explained by standard modifiable risk factors , 2017, European journal of preventive cardiology.

[16]  M. Creager,et al.  Alternative causes of myocardial ischemia in women: An update on spontaneous coronary artery dissection, vasospastic angina and coronary microvascular dysfunction , 2017, Vascular medicine.

[17]  S. Bangalore,et al.  Impact of Sex and Contact‐to‐Device Time on Clinical Outcomes in Acute ST‐Segment Elevation Myocardial Infarction—Findings From the National Cardiovascular Data Registry , 2017, Journal of the American Heart Association.

[18]  Harlan M Krumholz,et al.  Acute Myocardial Infarction in Women: A Scientific Statement From the American Heart Association , 2016, Circulation.

[19]  Deepak L. Bhatt,et al.  Cardiovascular Risk Factors and In-hospital Mortality in Acute Coronary Syndromes: Insights From the Canadian Global Registry of Acute Coronary Events. , 2015, The Canadian journal of cardiology.

[20]  G. Stone,et al.  Sex‐based differences in bleeding and long term adverse events after percutaneous coronary intervention for acute myocardial infarction: Three year results from the HORIZONS‐AMI trial , 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[21]  J. Ottervanger,et al.  Is the difference in outcome between men and women treated by primary percutaneous coronary intervention age dependent? Gender difference in STEMI stratified on age , 2013, European heart journal. Acute cardiovascular care.

[22]  J. Ornato,et al.  Number of coronary heart disease risk factors and mortality in patients with first myocardial infarction. , 2011, JAMA.

[23]  Barbara P. Yawn,et al.  Using nontraditional risk factors in coronary heart disease risk assessment: U.S. Preventive Services Task Force recommendation statement. , 2009, Annals of internal medicine.

[24]  George A Mensah,et al.  CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: overview. , 2004, Circulation.

[25]  S. Yusuf,et al.  Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study , 2004, The Lancet.

[26]  J P Ornato,et al.  Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain. , 2000, JAMA.

[27]  D. Levy,et al.  Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.

[28]  T. Dawber,et al.  II. Coronary Heart Disease in the Framingham Study , 1957 .